Mireille Gingras Gillings, (born 1962) is a US-based Canadian neurobiologist and entrepreneur.

She founded HUYA Bioscience International, a biotech consulting firm in 2004, and is the San Diego, California, company's CEO and Executive Chair.

[1][2] In 2010, Gillings' interest in China as a source of "research-intensive, expensive-to-develop medicines that are the stuff of patents and high profit margins" attracted the interest of Fortune magazine.

[3] Born in Montreal, Quebec, Gillings earned her PhD from Radboud University Nijmegen and has held postdoctoral fellowships at Bordeaux University in France and The Scripps Research Institute in La Jolla, California.

[6] Gillings is at least functional in several languages, including Mandarin, in addition to her native French.